Thymosin α1-Induced IL-15/RA Secretion Restrains HIV Latency In Vitro
Chen C, Xun J, Wang J, et al.
Summary
Thymosin α1 induced dendritic cells to secrete IL-15/retinoic acid complex, which helped restrain HIV latency in vitro, suggesting a potential role in HIV cure strategies.
Clinical Significance
Provides mechanistic insight into how thymosin α1 may contribute to HIV cure research through immune modulation.
Key Findings
- Thymosin α1 stimulated THP-1-derived dendritic cells to secrete IL-15/RA complex
- This secretion reactivated latent HIV in vitro
- Suggests thymosin α1 may play a role in "shock and kill" HIV cure strategies
- Novel mechanism involving dendritic cell activation
Clinical Relevance
HIV latency is a major barrier to cure. This research suggests thymosin α1's immune-modulating properties may be harnessed in combination approaches to reactivate and eliminate latent HIV reservoirs.
Source
İlgili Araştırma
IL-15 Plus Thymosin α1 Reduces Senescent Hepatic CD8+ T Cells in Liver Cancer via PI3K/AKT Suppression
The combination of IL-15 and thymosin α1 reduced senescent CD8+ T cells in hepatocellular carcinoma …
Thymalfasin Plus Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Cancer
Neoadjuvant immunochemotherapy combined with thymalfasin showed promising results in locally advance…
Peptide Angio-3 Attenuates Pulmonary Fibrosis Via Modulation of Coagulation Factor Xa-PAR-1 Signaling Axis
Angio-3, a 10-residue peptide derived from human plasminogen kringle 3, demonstrated significant ant…
Antimicrobial Peptides Show Promise as Cancer Therapeutics: A 2026 Systematic Review
A new review in Frontiers in Medicine evaluates antimicrobial peptides (AMPs) as anticancer agents, …